Delivery Order SPE2DB24D9144-SPE2DB25FCMQC
Award Date
4/22/25
Potential Completion Date
5/13/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 160 mg vials of the drug Kadcyla. The total potential value of the contract is $19,221.30, with a completion date of January 11, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $12,728.46 and has an ultimate completion date of April 29, 2025. It is for the delivery of 160 mg vials of the drug Kadcyla. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. also holds a larger $499,999,999 Indefinite Delivery Contract...
The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Kadcyla 100 mg vials. The $15,358.74 contract has a completion date of February 20, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that has received numerous prime and subcontracts from government agencies, primarily the Department of Veterans Affairs and Department of Defense, to deliver a wide range of...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the procurement of Kadcyla 160 mg vials. The $4,103.92 contract has a period of performance through May 16, 2024. DMS Pharmaceutical Group is an experienced pharmaceutical wholesaler that provides a wide range of branded and generic prescription drugs, biologics, and medical supplies to support the recurring medical needs of military health...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,713.36 award is for the supply of Kadcyla 160 mg vials, with a period of performance through November 18, 2022. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price...
The Defense Logistics Agency has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 160 mg vials of the drug KADCYLA. The order, valued at $31,565.44, has a completion date of January 16, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles to supply a wide range of pharmaceutical and medical products to the Department of Defense and military...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,358.74 contract is for the supply of Kadcyla 100 mg vials, with a period of performance through August 28, 2024. DMS Pharmaceutical Group holds a large single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued up to $499,999,999, which allows the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $33,942.56, is for the delivery of 160 mg vials of the drug Kadcyla. The contract has an ultimate completion date of March 17, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $20,478.24, is for the delivery of Kadcyla 100 mg vials. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, that runs through December 31, 2025. This single-award vehicle allows the...
The Defense Logistics Agency has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 160 milligram vials of the drug KADCYLA. The $41,039.20 contract has a completion date of February 8, 2024 and was awarded on January 18, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals and medical products to the...